| 000 | 01294 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512042646.0 | ||
| 264 | 0 | _c19890510 | |
| 008 | 198905s 0 0 eng d | ||
| 022 | _a0095-1137 | ||
| 024 | 7 |
_a10.1128/jcm.26.11.2361-2366.1988 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldstein, E J | |
| 245 | 0 | 0 |
_aAnnual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cNov 1988 |
||
| 300 |
_a2361-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBacteroides Infections _xepidemiology |
| 650 | 0 | 4 |
_aBacteroides fragilis _xdrug effects |
| 650 | 0 | 4 |
_aCefmetazole _xpharmacology |
| 650 | 0 | 4 |
_aCefotetan _xpharmacology |
| 650 | 0 | 4 |
_aCefoxitin _xpharmacology |
| 650 | 0 | 4 |
_aCeftizoxime _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aPeriodicity |
| 700 | 1 | _aCitron, D M | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 26 _gno. 11 _gp. 2361-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/jcm.26.11.2361-2366.1988 _zAvailable from publisher's website |
| 999 |
_c3241443 _d3241443 |
||